Zusammenfassung
Trotz der Entwicklung neuer Therapieverfahren ist der Myokardinfarkt weiterhin eine Erkrankung mit hoher Mortalität. Alle medikamentösen interventionellen und operativen Maßnahmen dienen dazu, diese zu senken und die Lebensqualität der Patienten zu erhöhen.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
The AIRE Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828
Bruggman J, Eberhard C (1993) FdM-Tabellen für die Praxis. Fortschr Med 111: 38/284, 285/39
Bussmann WD, Passek D, Seidel W, Kaltenbach M (1981) Reduction of CK and CK.MB indices of infarct size by intravenous nitroglycerin. Circulation 63: 615–622
The CAST Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321: 406–412
Cardiac Arrhythmia Suppression II Investigators (1992) Effect of the antiarrhythmia agent moricizine on survival after myocardial infarction. N Engl J Med 327: 227–233
ISIS-2 Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin both or neither among 17189 cases of suspected myocardial infarction: ISIS-2. Lancet 2: 349–60
ISIS-4 Collaborative Group (1993) Mündliche Mitteilung
Lüderitz B (1993) Therapie der Herzrhythmusstörungen, Leitfaden für Klinik und Praxis. Springer, Berlin Heidelberg New York Tokyo
Nademanee K, Singh BN, Stevenson WG, Weiss JN (1993) Amiodarone and Post-MJ Patients. Circulation 88: 764–774
Norwegian Multicenter Study (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807
The MDPIT Research Group (1988) The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319: 385–392
Pasternak RC, Braunwald E (1994) Acute myocardial infarction. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds) Harrison’s principles of internal medicine, 13th edn. McGraw-Hill, New York, p 1066
Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction. Circulation 81: 1161–1172
Pfeffer MA, Braunwald E, Moye LA et al. (1992) Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327: 669–677
Sharpe N, Murphy J, Smith H, Hannan S (1988) Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 334: 255–259
The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327: 685–691
Swedburg K, Held P, Kjekshus J et al. On behalf of the CONSENSUS II Study Group (1992) Effects of carly administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative North Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 327: 678–684
Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Betablockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27(5): 335–371
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Saborowski, F. (1995). Postinfarkttherapie. In: Unger, F., Mörl, H., Dieterich, H.A. (eds) Interventionen am Herzen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93558-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-93558-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-93559-6
Online ISBN: 978-3-642-93558-9
eBook Packages: Springer Book Archive